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Abstract PDGF-AB and TGF-ßl intervene in molluscan stress 
response, the former inhibiting and the latter inducing the release 
of norepinephrine and epinephrine from hemocytes. These amines 
are down-regulated even when TGF-ßl is added to hemolymph 
pre-incubated with PDGF-AB. The opposite behaviour is 
observed if the growth factors are reversed. The dopamine 
response is not affected in either case, even after the addition of 
CRH or ACTH. After pre-incubation with PDGF-AB or TGF-
ßl in the presence of CRH or ACTH, norepinephrine and 
epinephrine release falls. These findings suggest that when the 
interaction is between growth factors, the order of combination is 
crucial, while in cases where the interaction is between growth 
factors and other peptides, such as CRH and ACTH, the order is 
of no importance. 
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1. Introduction 
The corticotropin-releasing hormone (CRH) - adrenocorti-
cotropin hormone (ACTH) - biogenic amine axis is the main 
origin of stress response in vertebrates and in invertebrates 
(molluscs), even if there are differences in the manner in which 
the events associated to the release of biogenic amines takes 
place (see for review [1]). In invertebrates, the process is sim-
plified, for rather than several organs, such as the hypothal-
amus, pituitary and adrenal glands, being involved, the re-
sponse is concentrated in the phagocytic hemocytes, which 
harbour all the relevant molecules. 
Furthermore, studies on the relationship between cytokines 
and biogenic amine release have shown that, as in vertebrates, 
cytokines are also involved in invertebrate stress response [2-
4]. 
In this paper, we examine whether platelet-derived growth 
factor (PDGF)-AB and transforming growth factor (TGF)-ß l 
are able to provoke the release of biogenic amines from mol-
luscan hemocytes. It should be noted that the presence of 
P D G F - and TGFß-l ike molecules in several invertebrate im-
munocytes, including molluscs, has been demonstrated [5]. 
Moreover, P D G F - A B and T G F - ß l are able to stimulate cell 
migration and enhance phagocytosis in molluscan hemocytes 
[6]. 
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2. Materials and methods 
2.1. Animals 
Adult specimens of Viviparus ater (Cristofori and Jan, 1832) main-
tained in dechlorinated freshwater at room temperature were used. 
2.2. Sample preparation 
About 35 ml of hemolymph were collected in a Pasteur pipette from 
45 V. ater, by exerting pressure on the foot of each animal. The 
pooled hemolymph was divided into 11 portions (3 ml each one) 
and placed in plastic tubes. To 5 tubes the following substances 
were added: snail saline solution (SSS) (30 ul) (control sample) [7], 
platelet-derived growth factor (PDGF)-AB (Sigma Chem. Co., St. 
Louis, USA) (20 ng/ml final concentration), transforming growth fac-
tor (TGF)-ßl (Sigma) (5 pg/ml final concentration), human cortico-
tropin-releasing hormone (CRH) (Sigma) (10~8 M final concentra-
tion) and human adrenocorticotropin hormone (ACTH) (Sigma) 
(10~8 M final concentration). The concentrations used of the above-
mentioned peptides are active on molluscan hemocytes [1,6]. Of the 
6 remaining tubes, 3 were pre-incubated with PDGF-AB for 2 h 
before addition of TGF-ßl, CRH or ACTH, while the other 3 were 
pre-incubated with TGF-ßl for 2 h before adding PDGF-AB, CRH 
or ACTH. The tubes were then placed in the dark on a revolving 
mixer, incubated for 20 min at room temperature and immediately 
centrifuged (600 Xg for 15 min). After centrifugation, the supernatant 
(serum) and the pellet (hemocytes) were collected, and the amount of 
biogenic amines [norepinephrine (NA), epinephrine (A), dopamine 
(DA)] in the serum was immediately determined by liquid chromatog-
raphy. 
2.3. Determination of biogenic amines 
The serum was analyzed using a Clin-Rep-Catecholamine kit, which 
involves the extraction of biogenic amines by activated aluminium 
oxide and the de-absorption of the catecholamines with acid solution. 
50 (il of a solution of DHBA (3,4-dihydroxybenzylamine) (10 pg/ul) as 
an internal standard, 10 mg of aluminium oxide, and 400 ul of 2 M 
Tris buffer, pH 8.7, were added to 1.4 ml of serum. The mixture was 
shaken for 15 min in the dark at room temperature and centrifuged (1 
min), and the supernatant was aspirated and discarded. One ml of 
Tris buffer, pH 8.1 (0.2%), was added to the remaining sample, shaken 
for 1 min and then centrifuged (1 min). The supernatant was removed 
and discarded and the sample was washed 3 times. To elute catechol-
amines, the remaining sample was mixed with 100 ul of eluting acid 
solution (100 ul of 100% acetic acid, 50 ul of 10% sodium disulfite and 
50 ul of 5% EDTA in 10 ml of ultrapure water), shaken for 15 min in 
the dark at room temperature and then centrifuged for 4 min. The 
supernatant was removed with care, filtered with a 0.45 urn Millipore 
filter and injected (50 ul) directly into the Chromatographie system. 
This acid solution was stable for 2 days at 4°C, for 15 days at —20°C 
and for at least 2 months at —80°C. We investigated the stability of 
biogenic amines in serum and after extraction. Our results suggest that 
it is better to carry out extraction immediately and store the acid 
solution if is not possible to do the Chromatographie analysis. The 
most reliable calculation of the quantitative analysis of catechol-
amines was obtained using the internal standard (DHBA) method 
with a correction factor. 
2.4. Chemical reagents 
The substances investigated (NA, A, DA) and DHBA were ob-
tained from Sigma as salts or free compounds. Stock solutions con-
taining 100 ug/ml of the individual compounds were prepared in 0.1 M 
0014-5793/97/S17.00 © 1997 Federation of European Biochemical Societies. All rights reserved. 
P / 7 S 0 0 1 4 - 5 7 9 3 ( 9 7 ) 0 0 0 5 3 - 7 
E. Ottaviani et al.lFEBS Letters 403 (1997) 236-238 237 
Table l 
Concentrations of biogenic amines determined by HPLC in cell-free hemolymph (serum) of Viviparus ater after addition of 20 ng/ml PDGF-
AB, 5 pg/ml TGF-ßl, 10~8M CRH or 10~8M ACTH 
Saline PDGF-AB TGF-ßl CRH ACTH 
NA 
A 
DA 
436.00 ± 67.48' 
705.00 ±186.70 
1337.00 ±458.56 
130.00 ± 20.98b 
371.00± 100.35= 
1210.00 ±156.72 
634.00 ± 96.59= 
1673.00 ±280.31b 
1195.00 ±100.41 
795.00 ±225.12= 
712.00 ±352.78 
1448.00 ±245.26 
679.00 ± 35.08b 
1071.00± 142.66= 
1368.00 ±464.17 
NA, norepinephrme; A, epinephrine; DA, dopamine. 
"The mean ± standard deviation of three experiments is shown. Data are expressed as pg/ml. 
Statistical analysis was performed by Student «-test. hp < 0.01 and cp < 0.05 vs. saline (control). 
HCIO4 containing 4 mM NaHSCV These were kept frozen and 
freshly prepared every 2 weeks. Daily external standard mixture sol-
utions and DHBA internal standard solution were obtained by dilut-
ing stock solution to the working concentration with bi-distilled 
water. The water used for preparing standards and solvents was ob-
tained using a Milli-Q Water Purification System (Millipore). The 
Clin-Rep-Catecholamine kit was provided by RECIPE Pharma Ver-
triebs GmbH and Co. KG, München, Germany. 
2.5. Liquid chromatography system 
The HPLC apparatus consists of a Isocratic LC Pump (mod. 250 
Perkin Elmer) equipped with a degasser (ERC-3312-Erma), an auto-
matic injector Rheodyne 7125 (50 ul loop) and a Waters 460 electro-
chemical detector employing a three-electrode amperometric cell. The 
potential of the working electrode was maintained at +0.65 V vs. a 
silver/silver chloride reference electrode. The signal was recorded and 
elaborated with a Data System PE Nelson (mod. 1020 Perkin Elmer). 
Analysis was performed in isocratic mode at room temperature and at 
a flow rate of 1.2 ml/min, and lasted for 8 min. The mobile phase and 
the column employed were from the catecholamine kit purchased 
from RECIPE Pharma Vertriebs GmbH and Co. KG. 
2.6. Statistical analysis 
Student's two-tailed Mest was used to compare the biogenic amine 
release of control (presence of SSS) and treated samples (presence of 
PDGF-AB, TGF-ßl, CRH, ACTH), as well as to compare controls 
and samples obtained after pre-incubation of the hemolymph with the 
two growth factors. The results with PDGF-AB, TGF-ßl, CRH or 
ACTH alone were also compared with those obtained after pre-incu-
bation with one of the growth factors followed by the addition of 
CRH, ACTH or the other growth factor, respectively. 
3. Results 
The results reported in Table 1 show a significant decrease 
with respect to controls in the release of NA and A from 
hemocytes in the presence of PDGF-AB, while TGF-ßl was 
able to provoke a significant increase in these amines in the 
serum. Moreover, TGF-ßl was able to provoke the maximum 
release of A into the serum. Neither growth factor signifi-
cantly affects DA release. 
As expected, both CRH and ACTH were able to induce the 
release of biogenic amines. 
The situation changes when the hemolymph is pre-incu-
bated with the two growth factors. As shown in Table 2, 
pre-incubation with PDGF-AB followed by the addition of 
TGF-ßl, CRH or ACTH results in a general, significant de-
crease in the level of biogenic amines with respect to values 
following incubation of the hemolymph with the single mole-
cules (TGF-ßl, CRH, ACTH) (Table 1). NA concentrations 
following pre-incubation with PDGF-AB cannot be deter-
mined, because values were below the sensitivity threshold 
of the method. The concentration of A shows a significant 
decrease (/><0.01) with respect to incubation with TGF-ßl 
alone. The levels of DA are not significantly different from 
those obtained in the presence of TGF-ßl, CRH and ACTH 
used singularly (Table 1). 
Pre-incubation with TGF-ßl (Table 3) followed by the ad-
dition of PDGF-AB shows a significant increase in NA 
(p<0.0l), but no significant modification of the A and DA 
concentration with respect to incubation with PDGF-AB 
alone (Table 1). The addition of CRH or ACTH provokes a 
significant decrease in NA (p < 0.01) and a lower release of A, 
but again DA values not significantly different from those 
found when the hemolymph is incubated only with either 
CRH or ACTH (Table 1). 
4. Discussion 
We have shown that PDGF-AB and TGF-ßl are involved 
in different ways in the release of biogenic amines (NA, A, 
DA): PDGF-AB shows an inhibitory effect, while TGF-ßl 
can induce amine release. Moreover, as expected, CRH and 
ACTH also intervene in the release of biogenic amines. These 
most recent results reinforce our previous observations on 
stress response in molluscs [1,8]. We have demonstrated 
both that the key mediator molecules in molluscs are similar 
to those present in vertebrates, and that the pathway follows 
the same order and pattern, i.e. CRH, ACTH, and biogenic 
amines. In this perspective, the growth factors also play an 
important role in the molluscan stress response. Either di-
rectly or indirectly, they are able to up- or down-regulate 
the release of biogenic amines, and this phenomenon is par-
ticularly evident for NA and A. Moreover, the relationship 
between the two growth factors should be underlined. Pre-
Table 2 
Concentrations of biogenic amines determined by HPLC in cell-free hemolymph (serum) of Viviparus ater following addition of 5 pg/ml TGF-
ßl, 10~8M CRH or 10~8M ACTH after pre-incubation with 20 ng/ml PDGF-AB 
Saline TGF-ßl CRH ACTH 
NA 
A 
DA 
436.00 ± 67.48a 
705.00 ±186.70 
1337.00 ±458.56 
b.s. 
502.00 ± 94.69 
1151.00 ±270.49 
b.s. 
394.00 ±116.99 
1399.00 ±347.36 
b.s. 
530.00 ±55.25 
1330.00 ±99.43 
NA, norepinephrine; A, epinephrine; DA, dopamine. b.s., below the sensitivity of the HPLC assay. The detection limit is 20 pg. Statistical analysis 
was performed by Student Mest. 
aThe mean ± standard deviation of three experiments is shown. Data are expressed as pg/ml. 
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Table 3 
Concentrations of biogenic amines determined by HPLC in cell-free hemolymph (serum) of Viviparus ater following addition of 20 ng/ml 
PDGF-AB, 1(T8M CRH or 10_8M ACTH after pre-incubation with 5 pg/ml TGF-ßl 
Saline PDGF-AB CRH ACTH 
NA 436.00 ± 67.48a 481.00 ± 59.09 b.s. 351.00 ± 62.06 
A 705.00± 186.70 383.00± 16.26b 415.00±391.00 674.00±330.00 
DA 1337.00 ±458.56 1085.00 ±211.06 1437.00 ±327.65 1463.00 ±503.57 
NA, norepinephrine; A, epinephrine; DA, dopamine. b.s., below the sensitivity of the HPLC assay. The detection limit is 20 pg. Statistical analysis 
was performed by Student f-test. 
aThe mean ± standard deviation of three experiments is shown. Data are expressed as pg/ml. hp < 0.05 vs. Saline (control). 
incubation with the inhibitor PDGF-AB annuls the inducing 
power of TGF-ßl. While following pre-incubation with TGF-
ßl, PDGF-AB partially loses its inhibitory effect on the re-
lease of biogenic amines, i.e. NA. DA, however, is not af-
fected, and, we obtained the same DA values either with 
PDGF-AB and TGF-ßl used singularly, or when the hemo-
lymph was pre-incubated with one growth factor before the 
addition of the other. Similar behaviour is observed after ad-
dition of CRH or ACTH. 
Therefore, the behaviour of PDGF-AB and TGF-ßl with 
regard to CRH is similar to that observed with cytokines [3,4]. 
Indeed, using the same experimental approach, IL-2 was able 
to elicit the release of biogenic amines from hemocytes, but 
this response was significantly reduced when the hemolymph 
was incubated with CRH after pre-incubation with IL-2. This 
inhibitory effect was also observed with IL-la, IL-Iß, TNF-a 
and TNF-ß. 
This study demonstrates that the two growth factors act 
differently when variously combinated with other substances. 
If the interaction is between growth factors, the order of 
combination is crucial, while this order is not important 
when interaction is between growth factors and other pep-
tides. It should be emphasized that previous studies have 
shown that the action of a growth factor may depend on 
several parameters, such as the presence of other substances 
and the differentiation of target cells, etc. [9]. Indeed, TGF-ß 
stimulates the growth of some fibroblasts in the presence of 
PDGF, while the action is reversed in the presence of epider-
mal growth factor [10]. Moreover, PDGF acts in synergy with 
TGF-ß in stimulating DNA synthesis in sparse cultures of 
human embryonic fibroblasts [11]. 
On the whole, our data confirm from a phylogenetic point 
of view reports in the literature on mouse and man. Cytokines 
and growth factors are part of a common pool of polypep-
tides with regulatory function [12]. This and previous studies 
suggest that these substances also have overlapping and dis-
tinct biological properties in invertebrates. They are present in 
the same immunocytes, i.e. cells with phagocytic activity [5], 
are able to influence hemocyte migration and increase phag-
ocytic capacity [6] and can intervene in the stress response 
with either an inhibiting or inducing effect. 
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